Qinghua Xue

1.0k citations
34 papers · 887 indexed · h-index 17

Qinghua Xue

33 papers receiving 871 citations

Peers

Qinghua Xue
Comparison fields: 5 of 95
  • Immunology 355
  • Infectious Diseases 153
  • Cardiology and Cardiovascular Medicine 172
  • Animal Science and Zoology 70
  • Epidemiology 171
Replace Shih‐Yen Lo with:
Shih‐Yen Lo Taiwan
Andreas Dotzauer Germany
Ligang Zhou China
Elena V. Vassilieva United States
Te Du China
Shuai Yuan China
W.C. Hwang United States
Zhikuan Zhang Japan
Gregory P. McNerney United States
Qinghua Xue relative to Shih‐Yen Lo Taiwan Shih‐Yen Lo's profile →
Citations per field
00.5×1.5×1.8×
Shih‐Yen Lo · 1×
Citations per year

Countries citing papers authored by Qinghua Xue

Since Specialization
Citations

This map shows the geographic impact of Qinghua Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinghua Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinghua Xue more than expected).

Fields of papers citing papers by Qinghua Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinghua Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinghua Xue. The network helps show where Qinghua Xue may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Qinghua Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Qinghua Xue Line = papers co-authored together Qinghua Xue links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20249
3 202015
4 20207
5 201510
6 201437
7 20148
8 201318
9 201262
10 201117
11 201129
12
[Comparison of antiviral activities of porcine interferon type I and type II].
20097
13 20096
14 2009111
15 200917
16 200727
17 200719
18 20056
19
LD-pumped passively Q-switched red laser at 660 nm
20048
20
Diode-pumped, Cr:YAG passively Q-switched and mode-locked Nd:YVO4/KTP green laser
200317

About Qinghua Xue

Qinghua Xue is a scholar working on Developmental Neuroscience, Immunology and Biochemistry, having authored 34 papers that have together received 887 indexed citations. Recurring topics across this work include Solid State Laser Technologies (9 papers), Advanced Fiber Laser Technologies (8 papers), interferon and immune responses (7 papers), Photorefractive and Nonlinear Optics (7 papers), Cardiac and Coronary Surgery Techniques (5 papers), Viral Infections and Immunology Research (3 papers), Immune Response and Inflammation (3 papers) and Cardiac Ischemia and Reperfusion (3 papers). The work is most often cited by research in Immunology (355 citations), Infectious Diseases (153 citations) and Cardiology and Cardiovascular Medicine (172 citations). Qinghua Xue has collaborated with scholars based in China, United States and Venezuela. Frequent co-authors include Jianwei Wang, Xiaobo Lei, Qi Jin, Zhuo Zhou, Quan Zheng, Yikun Bu, Bin He, Xia Xiao, Wenjun Liu and Lei Sun. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026